190 related articles for article (PubMed ID: 19066716)
1. FGFR3-related dwarfism and cell signaling.
Harada D; Yamanaka Y; Ueda K; Tanaka H; Seino Y
J Bone Miner Metab; 2009; 27(1):9-15. PubMed ID: 19066716
[No Abstract] [Full Text] [Related]
2. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1.
Harada D; Yamanaka Y; Ueda K; Nishimura R; Morishima T; Seino Y; Tanaka H
Bone; 2007 Aug; 41(2):273-81. PubMed ID: 17561467
[TBL] [Abstract][Full Text] [Related]
3. Dephosphorylation is the mechanism of fibroblast growth factor inhibition of guanylyl cyclase-B.
Robinson JW; Egbert JR; Davydova J; Schmidt H; Jaffe LA; Potter LR
Cell Signal; 2017 Dec; 40():222-229. PubMed ID: 28964968
[TBL] [Abstract][Full Text] [Related]
4. Does the co-occurrence of FGFR3 gene mutation in hypochondroplasia, medial temporal lobe dysgenesis, and focal epilepsy suggest a syndrome?
Romeo A; Lodi M; Viri M; Parente E; Baldi M; Righini A; Milani D
Pediatr Neurol; 2014 Apr; 50(4):427-30. PubMed ID: 24630288
[TBL] [Abstract][Full Text] [Related]
5. De novo stop-lost germline mutation in FGFR3 causes severe chondrodysplasia in the progeny of a Holstein bull.
Häfliger IM; Letko A; Murgiano L; Drögemüller C
Anim Genet; 2020 Jun; 51(3):466-469. PubMed ID: 32239744
[TBL] [Abstract][Full Text] [Related]
6. [Mutation analysis of FGFR3 gene in a family featuring hereditary dwarfism].
Zhang Q; Jiang HO; Quan QL; Li J; He T; Huang XS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):705-7. PubMed ID: 22161110
[TBL] [Abstract][Full Text] [Related]
7. Familial hypochondroplasia and acanthosis nigricans with FGFR3 K650T mutation.
Cossiez Cacard MA; Coulombe J; Bernard P; Kaci N; Bressieux JM; Souchon PF; Motte J; Legeai-Mallet L; Hadj-Rabia S; Eschard C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):897-8. PubMed ID: 25809207
[No Abstract] [Full Text] [Related]
8. FGFR3 biology and skeletal disease.
Narayana J; Horton WA
Connect Tissue Res; 2015 Nov; 56(6):427-33. PubMed ID: 26075305
[TBL] [Abstract][Full Text] [Related]
9. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.
Li C; Chen L; Iwata T; Kitagawa M; Fu XY; Deng CX
Hum Mol Genet; 1999 Jan; 8(1):35-44. PubMed ID: 9887329
[TBL] [Abstract][Full Text] [Related]
10. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
11. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
[TBL] [Abstract][Full Text] [Related]
12. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
[TBL] [Abstract][Full Text] [Related]
13. Trabecular bone microarchitecture analysis, a way for an early detection of genetic dwarfism? Case study of a dwarf mother's offspring.
Colombo A; Hoogland M; Coqueugniot H; Dutour O; Waters-Rist A
Int J Paleopathol; 2018 Mar; 20():65-71. PubMed ID: 29496218
[TBL] [Abstract][Full Text] [Related]
14. FGFR3 targeting strategies for achondroplasia.
Laederich MB; Horton WA
Expert Rev Mol Med; 2012 Jan; 14():e11. PubMed ID: 22559284
[TBL] [Abstract][Full Text] [Related]
15. An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth.
Mugniery E; Dacquin R; Marty C; Benoist-Lasselin C; de Vernejoul MC; Jurdic P; Munnich A; Geoffroy V; Legeai-Mallet L
Hum Mol Genet; 2012 Jun; 21(11):2503-13. PubMed ID: 22367969
[TBL] [Abstract][Full Text] [Related]
16. [Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasia].
Tanaka H
Clin Calcium; 2010 Oct; 20(10):1490-6. PubMed ID: 20890030
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage.
Krejci P; Krakow D; Mekikian PB; Wilcox WR
Pediatr Res; 2007 Mar; 61(3):267-72. PubMed ID: 17314681
[TBL] [Abstract][Full Text] [Related]
18. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
Sarabipour S; Hristova K
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging and neurological findings in patients with hypochondroplasia and FGFR3 N540K mutation.
Linnankivi T; Mäkitie O; Valanne L; Toiviainen-Salo S
Am J Med Genet A; 2012 Dec; 158A(12):3119-25. PubMed ID: 23165795
[TBL] [Abstract][Full Text] [Related]
20. Epileptic phenotype of FGFR3-related bilateral medial temporal lobe dysgenesis.
Okazaki T; Saito Y; Ueda R; Awashima T; Nishimura Y; Yuasa I; Shinohara Y; Adachi K; Sasaki M; Nanba E; Maegaki Y
Brain Dev; 2017 Jan; 39(1):67-71. PubMed ID: 27485793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
